Rush Ryan B, Rush Sloan W
Panhandle Eye Group, Amarillo, TX, USA.
Department of Surgery, Texas Tech University Health Science Center, Amarillo, TX, USA.
J Vitreoretin Dis. 2025 Aug 5:24741264251359851. doi: 10.1177/24741264251359851.
To evaluate the benefits of pars plana vitrectomy (PPV) in subjects with poor visual acuity (VA) and a chronic macula-involving tractional retinal detachment (TRD) secondary to proliferative diabetic retinopathy (PDR). A retrospective, case-controlled chart review was conducted, and patients were divided into (1) a study group that underwent PPV and (2) a control group in which PPV was declined. Both study and control subjects had a baseline VA of hand motions at 3 feet or worse, a PDR-associated macula-involving TRD for more than 6 months, and at least 12 months of follow-up. A total of 175 subjects were analyzed. There were no differences in baseline characteristics between cohorts. The change in VA was improved by 0.78 logMAR (95% CI, 0.64-0.90) in the study group compared with 0.03 logMAR (95% CI, -0.15 to 0.22) in the control group ( .0001). The rates of achieving 20/200 or better Snellen VA and 20/50 or better Snellen VA were increased in the study group compared with the control group ( .0001 and .007, respectively), and the rates of becoming no light perception, developing neovascular glaucoma, or undergoing enucleation/evisceration during the study period were higher in the control group compared with the study group ( = .02, .0001, and = .03, respectively). Patients with PDR with poor VA and a macula-involving TRD of more than 6 months duration still may have a more meaningful improvement in vision and fewer adverse events when PPV is performed than when PPV is declined in favor of less invasive options.
评估玻璃体切除术(PPV)对视力差(VA)且患有增生性糖尿病视网膜病变(PDR)继发的慢性黄斑受累牵引性视网膜脱离(TRD)患者的益处。进行了一项回顾性病例对照图表审查,患者被分为:(1)接受PPV的研究组;(2)拒绝接受PPV的对照组。研究组和对照组的基线视力均为3英尺处手动或更差,伴有PDR相关的黄斑受累TRD超过6个月,且至少随访12个月。共分析了175名受试者。两组间基线特征无差异。研究组的视力变化改善了0.78 logMAR(95%CI,0.64 - 0.90),而对照组为0.03 logMAR(95%CI, - 0.15至0.22)(P <.0001)。与对照组相比,研究组达到20/200或更好的Snellen视力以及20/50或更好的Snellen视力的比例增加(分别为P <.0001和P <.007),且在研究期间,对照组无光感、发生新生血管性青光眼或接受眼球摘除/眼内容剜除术的比例高于研究组(分别为P =.02、P <.0001和P =.03)。患有PDR且视力差、黄斑受累TRD持续超过6个月的患者,接受PPV时视力改善可能更显著,不良事件也比拒绝PPV而选择侵入性较小的治疗方案时更少。